Kimberly A. Bergstrom
Kimberly A. Bergstrom publishes mostly in Oncology, Economics and Econometrics and Hematology, on topics such as Cancer Treatment and Pharmacology, Economic and Financial Impacts of Cancer and Medication Adherence and Compliance.
- World rank
- #5,359,165 of 7,710,434 ranked researchers
- Rank in United States
- #1,362,543 of 1,627,098
- Works
- 15
- Citations
- 10
- Citations per work
- 0.7
What does Kimberly A. Bergstrom research?
Kimberly A. Bergstrom's work is mostly in Medicine (54%), Economics, Econometrics and Finance (27%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences853.7%
- Medicine853.7%
- Social Sciences426.8%
- Everything else319.5%
- 1Oncology29% of their works
- 2Economics and Econometrics27% of their works
- 3Hematology7% of their works
- 4Family Practice7% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Surgery5% of their works
Research topics
- Cancer Treatment and Pharmacology
- Economic and Financial Impacts of Cancer
- Medication Adherence and Compliance
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- Pharmaceutical Economics and Policy
- Breast Cancer Treatment Studies
Which keywords describe Kimberly A. Bergstrom's research?
The keywords of their largest research topics: Quality of Life, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Cost of Care, Financial Toxicity, Chemotherapy, Cost-effectiveness Analysis and Health Utility Measures.
- Breast Tumours
- Generic Drugs
- Drug Development Costs
- Antimicrobial Agents
- Molecular Subtypes
- Health Utility Measures
- Chemotherapy
- Cost of Care
- Chemotherapy-Induced Peripheral Neuropathy
- Quality of Life
- Taxanes
- Financial Toxicity
- Cost-effectiveness Analysis
- Medication Adherence
- Treatment Adherence
- Cetuximab
- Febrile Neutropenia
- KRAS Mutations
- Gene Expression
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Quality of Life102 topics
- Chemotherapy-Induced Peripheral Neuropathy71 topic
- Taxanes71 topic
- Cost of Care61 topic
- Financial Toxicity61 topic
- Chemotherapy42 topics
- Cost-effectiveness Analysis31 topic
- Health Utility Measures31 topic
- Medication Adherence31 topic
- Molecular Subtypes32 topics
- Treatment Adherence31 topic
- Antimicrobial Agents21 topic
- Cetuximab21 topic
- Drug Development Costs21 topic
- Febrile Neutropenia21 topic
- Generic Drugs21 topic
- KRAS Mutations21 topic
- Breast Tumours11 topic
- Gene Expression11 topic
Where does Kimberly A. Bergstrom work?
Kimberly A. Bergstrom's main affiliation in the publication record is McKesson (United States), United States.
How many publications and citations does Kimberly A. Bergstrom have?
OpenAlex counts 15 works and 10 citations for Kimberly A. Bergstrom, an h-index of 3, ranking #5,359,165 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kimberly A. Bergstrom. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.